'Help us save little Éabha.' Family make appeal for baby's overseas treatment
Éabha Duggan, born on June 24, 2024, has been diagnosed with a rare and serious genetic condition that requires a bone marrow transplant – a treatment not currently available in Ireland.
Her only option is to travel to Prinses Máxima Centrum in Utrecht, a world-leading specialist children's hospital in the Netherlands.
The Duggan family of Mayo and Galway are now making an urgent public appeal for financial support as their one-year-old daughter prepares for the life-saving bone marrow transplant in the coming weeks.
For parents Tommy (from Bekan, Claremorris, Mayo) and Martina Duggan (originally from Eyrecourt, Galway), this is an unimaginable second journey down a path of profound sorrow.
Their eldest daughter, Saoirse, bravely battled leukaemia after being diagnosed in late 2023. She underwent a bone marrow transplant in February 2024, but tragically, the disease returned months later, and she passed away peacefully on June 15, 2025, surrounded by love.
"To face such loss and now fight for another child's life is more than any family should have to bear," says Éabha's aunt, who has launched a fundraising campaign with the family's permission.
"While the medical costs for Éabha's transplant are covered by the HSE, the overwhelming financial burden of travel, and related living expenses in the Netherlands falls entirely on the family."
Time is critical for Éabha. The "Together for Éabha" GoFundMe campaign has been established in response to the many friends, neighbours, and kind-hearted people who've asked how they can help.
This initiative aims to alleviate the significant financial strain, allowing Tommy and Martina to focus solely on their daughter's treatment and recovery.
All donations will go directly to the Duggan family to support Éabha's medical care and associated costs. To donate to the fundraiser, head here.
Subscribe to our newsletter for the latest news from the Irish Mirror direct to your inbox: Sign up here.
The Irish Mirror's Crime Writers Michael O'Toole and Paul Healy are writing a new weekly newsletter called Crime Ireland. Click here to sign up and get it delivered to your inbox every week
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
5 hours ago
- Irish Examiner
Irish Examiner view: Delays to colonoscopy tests could be a matter of life or death
This week, we learned that thousands of people have been waiting far too long for vital cancer testing procedures, a problem which seems to be getting worse. Some 2,764 people have waited between 29 and 60 days for an urgent colonoscopy between January and May this year. According to the guidelines issued by the HSE, those with symptoms of bowel cancer should be seen within 28 days. That means some people have been waiting for over twice as long as the recommended time period for this vital intervention. To make matters worse, that number appears to be increasing, as 3,623 people were waiting longer than the recommended timeframe in 2024. The Irish Cancer Society pointed out that in 2017, no patient in Ireland had to wait longer than 28 days for an urgent colonoscopy, yet if the current trend continues through 2025, more than 6,500 people will not be seen within the 28-day period. The society's description of this development as a shocking deterioration in service, which is putting lives at risk, cannot be contradicted. This may seem at first glance yet another health service fiasco, one in a long line of similar disasters. But bowel cancer is a particular challenge. It is the second most common cancer in men, the third most common cancer in women, and the third leading cause of cancer death in Ireland. The Health Information and Quality Authority (Hiqa) said this months screening from the age of 50 was likely to be effective in terms of reducing deaths from colorectal cancer. However, plans for earlier screening are meaningless if that screening cannot be carried out. The long waiting times for colonoscopies which were revealed this week are a disheartening reminder that even established processes can break down, given the deterioration in waiting times between 2017 and the present. Strategies conceived with the best of intentions count for little if they cannot be put into practice. Failings of a justice system The man responsible for the killing of Irish soldier Private Seán Rooney was sentenced to death at a military tribunal in Beirut, Lebanon, this week. According to Lebanese media reports, Mohammad Ayyad was sentenced to death and fined 100m Lebanese pounds, or approximately €970. The remains of Irish UN peacekeeping soldier Seán Rooney arriving at Casement Aerodrome, Baldonnell, Co Dublin, in December 2022. Pte Rooney, from Newtowncunningham, Co Donegal, was killed on active service when his convoy came under attack in Lebanon. Another defendant was sentenced to three months, while yet another received one month: They were both fined as well. Ayyad was not in court for the sentencing however, while local media have reported that Lebanon has not carried out an execution in decades — so he is likely to receive a prison sentence instead. Pt Rooney, of Newtowncunningham, Donegal, was killed when a UN peacekeeping force was targeted in an attack on their vehicle in at Al-Aqbiya, Lebanon, in December 2022. He was 24 years old. Those responsible have received light sentences, with the exception of one individual who remains at large in the country and did not even have to attend the sentencing. Concerns have been raised repeatedly about the progress of this case, and the verdicts issued this week show the validity of those concerns. A justice system in which a killer does not even have to be present in court when sentenced to death hardly seems fit for purpose. The Rooney family, which has already had to deal with the trauma of losing a loved one, has been badly let down by that justice system. Taoiseach Micheál Martin weighed in on the matter yesterday when saying that the case had taken too long and that some of the sentences issued were unduly lenient. It should also be pointed out, perhaps, that earlier this year the Taoiseach also said: 'Hezbollah are responsible, in my view, for the murder of Seán Rooney.' Some armchair activists might bear that in mind when signalling their advocacy for certain groups. Pt Rooney made the ultimate sacrifice for peace and his family deserve the support of all. What's your view on this issue? You can tell us here New Garda commissioner The next Garda commissioner was announced on Tuesday, with Justin Kelly — who was appointed deputy commissioner for security, strategy, and governance in October 2024 — taking over from the outgoing commissioner, Drew Harris. Justice minister Jim O'Callaghan, incoming Garda commissioner Justin Kelly, Taoiseach Micheál Martin, and current Garda Commissioner Drew Harris, at Government Buildings in Dublin as Mr Kelly was announced as the next Garda commissioner. Picture: Liam McBurney/PA The process was far from straightforward, given the reticence of some senior officers to apply for the post because of pension implications. At one point, it was even suggested that those pension implications might mean only applicants outside Ireland would apply for the position. This is not to cast aspersions on such applicants, but at this fraught time in Irish life, it is surely preferable to have someone at the helm of the national police force who is already familiar with the particular challenges facing An Garda Síochána. That is certainly true of Mr Kelly, to judge by his policing background, which includes stints as assistant commissioner with responsibility for serious and organised crime, as well as detective chief superintendent in the Garda counter-terrorism unit. The rise of the far right, the ongoing threat of drugs gangs, the operation of rogue states in Ireland, the shadow cast by cybercrime — these are all challenges requiring urgent attention. Morale and standards within the force will also be scrutinised. Mr Kelly's appointment coincided with reports of a former garda being jailed for seven years for impersonating a colleague online, and inciting men to come to her home and rape her. The new commissioner's in-tray is already full. Best wishes to him. Read More Irish Examiner view: State must be ready to step in
Irish Independent
8 hours ago
- Irish Independent
Explainer: Are we any clearer on the EU-US trade deal agreed at the weekend, and what happens next?
A. They are. The White House and the European Commission have each published a 'fact sheet' setting out more details in the framework deal. The most important point from an Irish point of view is confirmation that the tariff on exports of pharmaceutical products from Europe to the US will be 15pc. The multinationals based here, such as Pfizer and Eli Lilly, export about €40bn of pharma to the US each year.
Irish Examiner
10 hours ago
- Irish Examiner
MSD won't close Irish sites as part of $3bn cutbacks
Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. MSD yesterday announced a global cost-cutting exercise as it prepares for generic competition to its Irish-manufactured cancer drug Keytruda, the world's best-selling medicine, which is predominantly made in Ireland. The company will cut administrative, sales and research jobs, with increased focus on the US market. It has not said where the roles will be lost or if any Irish workers will be among those affected. However, a spokesperson told the Irish Examiner: "The restructuring announced today does not include site closures in Ireland." MSD employs more than 3,000 people at eight locations in Ireland. These include MSD Brinny in Co Cork specialising in development and manufacture of innovative novel vaccines and testing of immuno-oncology medicines; three facilities in Dublin (MSD Biotech, MSD Blackrock, and MSD Red Oak North); MSD Carlow; MSD Dunboyne in Co Meath; MSD Ballydine in Co Tipperary, the company's first Irish site; and MSD Dundalk, the former WuXi Vaccines sites acquired in January. The cost cuts will include $1.7bn (€1.47bn) in annual savings from the elimination of certain administrative, sales and R&D positions, MSD said. The company expects the restructuring to be completed by the end of 2027, the year before Keytruda's key patents expire and the drug faces US government price cuts. The company said it plans to reinvest the savings into developing new drugs and launching new products. EU-branded medicines will face 15% import tariffs under the new transatlantic trade deal agreed between the European bloc and the US at the weekend. Like many other pharmaceutical firms based in Ireland, MSD had stockpiled doses of Keytruda manufactured in Ireland, to protect itself from tariffs imposed in 2025. MSD previously disclosed plans to invest more than $9bn (€7.78bn) in US manufacturing over the next four years, part of an effort to make more of its medicines in the US. The company reiterated that it expects to spend $200m (€172m) on tariffs in 2025, a number that reflects levies already in place and doesn't account for future tariffs on pharmaceuticals.
